Adaptimmune Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 29, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	6	133	163	224	515	682
Market Cap Growth	-95.86%	-18.29%	-27.20%	-56.55%	-24.48%	506.47%
Enterprise Value	25	25	40	58	327	374
PS Ratio	0.11	0.77	2.99	8.81	95.26	210.78
PB Ratio	-0.10	11.63	4.56	2.92	2.84	2.44
P/TBV Ratio	-	17.30	4.60	2.94	2.86	2.46
P/FCF Ratio	-	-	-	-	271.82	-
P/OCF Ratio	-	-	-	-	54.60	-
EV/Sales Ratio	0.46	0.15	0.73	2.28	60.44	115.73
EV/FCF Ratio	-0.15	-	-	-	172.44	-
Debt / Equity Ratio	-0.69	6.26	0.64	0.28	0.12	0.07
Debt / FCF Ratio	-	-	-	-	11.82	-
Asset Turnover	0.29	0.67	0.20	0.07	0.01	0.01
Inventory Turnover	20.28	34.25	97.02	126.15	78.45	51.66
Quick Ratio	1.07	2.60	2.66	3.76	6.45	9.96
Current Ratio	1.52	2.92	2.85	3.96	6.64	10.19
Return on Equity (ROE)	-1341.10%	-275.75%	-187.61%	-114.97%	-57.78%	-55.97%
Return on Assets (ROA)	-40.86%	-12.39%	-26.71%	-25.67%	-22.03%	-26.36%
Return on Capital Employed (ROCE)	-186.90%	-28.90%	-62.30%	-62.00%	-39.90%	-32.40%
Earnings Yield	-2314.00%	-51.37%	-63.22%	-69.17%	-26.99%	-15.59%
FCF Yield	-2612.68%	-53.75%	-80.82%	-71.60%	0.37%	-6.70%
Buyback Yield / Dilution	-8.53%	-25.48%	-24.73%	-3.47%	-9.37%	-35.72%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.